← Open Payments lookup

ROSEMARY ONWUKA: Open Payments

NPI 1154826089 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,686 in 15 payments from 10 companies in 2025. Trend: 2023 $1,231 · 2024 $2,059 · 2025 $1,686

Food & beverage: $1,686
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$399
Janssen Pharmaceuticals, Inc3$374
ABBVIE INC.2$249
Alkermes, Inc.1$123
AstraZeneca Pharmaceuticals LP1$122
ViiV Healthcare Company1$122
Otsuka America Pharmaceutical, Inc.1$113
E.R. Squibb & Sons, L.L.C.1$112
Teva Pharmaceuticals USA, Inc.1$54
Exact Sciences Corporation1$19

Products named: CAPLYTA, INVEGA SUSTENNA, VRAYLAR, LYBALVI, DATROWAY, APRETUDE, ABILIFY MAINTENA, COBENFY.

Industry payments across CA — which companies pay providers there.